Millham Robert D 4
4 · Odonate Therapeutics, Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Millham Robert D
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-02+22,878→ 22,878 totalExercise: $24.73Exp: 2028-01-02→ Common Stock (22,878 underlying)
Footnotes (1)
- [F1]The stock options vest with respect to 25% of the underlying shares on 01/02/2019, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.